title: Topiramate versus migraine: which is the cause of glaucomatous visual field defects?
authors.forename: Silvia
authors.initials: S
authors.lastname: Di Legge
authors.forename: Gianluca
authors.initials: G
authors.lastname: Bruti
authors.forename: Vittorio
authors.initials: V
authors.lastname: Di Piero
authors.forename: Gianluigi
authors.initials: G
authors.lastname: Lenzi
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D005632:Fructose / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005901:Glaucoma / Q000139:chemically induced* / Q000209:etiology; D006801:Humans; D008881:Migraine Disorders / Q000150:complications / Q000517:prevention & control*; D000077236:Topiramate; D014786:Vision Disorders / Q000139:chemically induced / Q000209:etiology; D014794:Visual Fields
chemical_list: D000927:Anticonvulsants; D000077236:Topiramate; D005632:Fructose